Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
Poly(dA:dT) Oxidative stress induces MUC5AC expression through mitochondrial damage-depen... 2023 FASEB Bioadv. Nishida Y. et al. DOI: 10.1096/fba.2022-00081
2'3'-cGAMP Manganese Mediates Its Antiviral Functions in a cGAS-STING Pathway Independen... 2023 Viruses Sun S. et al. DOI: 10.3390/v15030646
Poly(dA:dT) Manganese Mediates Its Antiviral Functions in a cGAS-STING Pathway Independen... 2023 Viruses Sun S. et al. DOI: 10.3390/v15030646
Blasticidin The origin of long-chain fatty acids required for de novo ether lipid/plasmal... 2023 J Lipid Res. Chornyi S. et al. DOI: 10.1016/j.jlr.2023.100364
Recombinant anti-PD-L1 antibodies (D265A) - InvivoFit™ Tumor-targeted superantigens produce curative tumor immunity with induction o... 2023 J Transl Med. Azulay M. et al. DOI: 10.1186/s12967-023-04064-z
Poly(dA:dT) A potential anti-HIV-1 compound, Q308, inhibits HSV-2 infection and replicati... 2023 Biomed Pharmacother. Zhang X. et al. DOI: 10.1016/j.biopha.2023.114595
CFA The lactate dehydrogenase (LDH) isoenzyme spectrum enables optimally controll... 2023 Sci Adv. Chen X. et al. DOI: 10.1126/sciadv.add9554
OVA peptides The lactate dehydrogenase (LDH) isoenzyme spectrum enables optimally controll... 2023 Sci Adv. Chen X. et al. DOI: 10.1126/sciadv.add9554
IL12elasti (p40::p35) Fusion peptide is superior to co-expressing subunits for arming oncolytic her... 2023 Commun Med (Lond). Fukuhara H. et al. DOI: 10.1038/s43856-023-00270-4
Anti-hIL-6 Neutralizing mAb Indoxyl-sulfate activation of the AhR- NF-κB pathway promotes interleukin-6 s... 2023 J Mol Cell Cardiol. Candellier A. et al. DOI: 10.1016/j.yjmcc.2023.03.011
Poly(I:C) HMW Type I interferon signaling in malignant blasts contributes to treatment effi... 2023 Cell Death Dis. Holicek P. et al. DOI: 10.1038/s41419-023-05728-w
ODN 2216 - TLR9 ligand Type I interferon signaling in malignant blasts contributes to treatment effi... 2023 Cell Death Dis. Holicek P. et al. DOI: 10.1038/s41419-023-05728-w
B16-Blue™ ISG Cells Epigenetic state determines the in vivo efficacy of STING agonist therapy. 2023 Nat Commun. Falahat R. et al. DOI: 10.1038/s41467-023-37217-1
B16-Blue™ ISG-KO-STING Cells Epigenetic state determines the in vivo efficacy of STING agonist therapy. 2023 Nat Commun. Falahat R. et al. DOI: 10.1038/s41467-023-37217-1
Zeocin® Epigenetic state determines the in vivo efficacy of STING agonist therapy. 2023 Nat Commun. Falahat R. et al. DOI: 10.1038/s41467-023-37217-1
Ionomycin Multiple Immune Defects in Two Patients with Novel DOCK2 Mutations Result in ... 2023 J Clin Immunol. Li W. et al. DOI: 10.1007/s10875-023-01466-y
PHA-P Multiple Immune Defects in Two Patients with Novel DOCK2 Mutations Result in ... 2023 J Clin Immunol. Li W. et al. DOI: 10.1007/s10875-023-01466-y
Zeocin® A novel Reelin construct, R36, recovered behavioral deficits in the heterozyg... 2023 Eur J Neurosci. Morrill N.K. et al. DOI: 10.1111/ejn.15971
2'3'-cGAMP Saturated fatty acids dampen the immunogenicity of cancer by suppressing STING. 2023 Cell Rep. Heath B.R. et al. DOI: 10.1016/j.celrep.2023.112303
ISD Saturated fatty acids dampen the immunogenicity of cancer by suppressing STING. 2023 Cell Rep. Heath B.R. et al. DOI: 10.1016/j.celrep.2023.112303

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty